Table 2 Summary of clinical and pathological factors in the Australian, UK GWAS and TCGA ovarian cancer datasets.
| Â | Australian dataset | UK GWAS dataset | TCGA dataset |
|---|---|---|---|
| Â | n* (%) | n* (%) | n* (%) |
Age group | Â | Â | |
   <40 | 21 (7) | 97 (5) | 7 (2) |
   40-49 | 51 (16) | 316 (17) | 74 (19) |
   50-59 | 85 (26) | 653 (36) | 123 (31) |
   60-69 | 99 (31) | 594 (33) | 97 (24) |
   70+ | 63 (20) | 155 (9) | 96 (24) |
FIGO stage | Â | Â | |
   I | 54 (18) | 586 (44) | 8 (2) |
   II | 35 (11) | 162 (12) | 12 (3) |
   III | 192 (63) | 507 (38) | 312 (79) |
   IV | 26 (8) | 80 (6) | 65 (16) |
Histological grade | Â | Â | |
well differentiated | 41 (14) | 239 (18) | 2 (1) |
moderately differentiated | 94 (32) | 418 (32) | 44 (11) |
poor/undifferentiated | 156 (54) | 643 (50) | 344 (88) |
Histological subtype | Â | Â | |
   serous | 199 (64) | 867 (54) | 397 (100) |
   endometrioid | 35 (11) | 200 (13) |  |
   mucinuous | 23 (8) | 320 (20) |  |
   clear cell | 21 (7) | 173 (11) |  |
   other | 32 (10) | 40 (2) |  |